Jane L. Armstrong
Sunderland, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Utility of Combined Immunohistochemical Staining for AMBRA1 and Loricrin for Improving the Pathologic Diagnosis of High-Grade Dysplastic Nevi.
Journal: The American Journal of dermatopathology
Published: June 26, 2026
Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells.
Journal: FEBS open bio
Published: September 03, 2025
Outcome of preterm infants (<30 weeks) born to mothers who smoked: propensity score matching study.
Journal: BMJ paediatrics open
Published: July 23, 2025
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Journal: The British journal of dermatology
Published: July 06, 2023
Research Techniques Made Simple: Analysis of Autophagy in the Skin.
Journal: The Journal of investigative dermatology
Published: July 22, 2020
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Journal: Autophagy
Published: January 23, 2016
A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion.
Journal: Molecular cancer therapeutics
Published: May 14, 2015
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
Journal: The Journal of investigative dermatology
Published: November 05, 2014
Prognostic impact of p62 expression in cutaneous malignant melanoma.
Journal: The Journal of investigative dermatology
Published: November 26, 2013
Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma.
Journal: Experimental dermatology
Published: September 24, 2013
Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates.
Journal: Bioorganic & medicinal chemistry
Published: July 05, 2012
Last Updated: 09/26/2026